Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q2 2023 · 10-Q
Revenue$7.77M$7.77M+1.8% vs Q2 2022 Net Income$220.98K$220.98K−65.2% vs Q2 2022 EPS Diluted$0.03$0.03−57.1% vs Q2 2022 Operating Income$1,027,898−13.9% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$531,657−67.6% Margins · derivedOperating margin13.2%−2.4 pt vs Q2 2022
Net margin2.8%−5.5 pt vs Q2 2022
ended May 31, 2023 · filed Jul 14, 2023 · 44 d after period end